SCANPHARM A/S: Financial statements 2021
CVR: 16279099
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
SCANPHARM A/S (CVR 16279099) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 11,259,429 and a net result of DKK -10,870,586 compared with DKK -18,941,298 the year before. That is an increase of 120% compared with the year before. Equity in the 2021 report amounted to DKK 1,500,000. The solvency ratio was 5.2%. The company had 40 employees in the financial year.
- Gross Profit
- DKK 11,259,429
- Profit/Loss
- DKK -10,870,586
- Equity
- DKK 1,500,000
- Total Assets
- DKK 28,911,167
- Employees
- 40
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 11.3 mio. | -10.9 mio. | 1.5 mio. | 40 |
| 2020 | - | 5.1 mio. | -18.9 mio. | 1.9 mio. | 40 |
| 2019 | - | 17.8 mio. | -4 mio. | 5.9 mio. | 42 |
| 2018 | - | 19.6 mio. | -2.9 mio. | 9.9 mio. | 46 |
| 2017 | - | 19.1 mio. | -228 t. | 12.7 mio. | 43 |
Official annual report
Find more companies like SCANPHARM A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
SCANPHARM A/S has published its annual report for 2020. Gross profit came to DKK 5,118,414, and the net result was DKK -18,941,298.
About SCANPHARM A/S
SCANPHARM A/S is a Danish company of the type Aktieselskab based in Birkerød, founded in 1992. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named SCANPHARM A/S AF 1992 and A/S SCANPHARM AF 1992. The management consists of Andreas Bjørn Jensen. The board consists of Janus Doré Pagh (chair), Andreas Bjørn Jensen and Hanne Bjørn Jensen. The company is owned by CHLOPETHAN A/S and Peluli Holding ApS. The company has 42 employees (2026). In 2025, the company reported a gross profit of DKK 29,716,677 and a net result of DKK 962,722 compared with DKK 582,684 the year before. Equity in the 2025 report amounted to DKK 3,045,406.